hemagglutin
ha
activ
porcin
epidem
diarrhea
viru
pedv
investig
two
celladapt
strain
pedv
subject
ha
test
erythrocyt
variou
origin
strain
show
ha
activ
rabbit
erythrocyt
treatment
trypsin
neuraminidas
optim
condit
induc
ha
activ
pedv
h
incub
use
phosphatebuff
salin
contain
bsa
result
suggest
ha
activ
pedv
like
caus
proteolyt
action
could
develop
new
diagnost
method
rapidli
detect
differenti
pedv
infect
enter
diseas
porcin
epidem
diarrhea
viru
pedv
member
famili
coronavirida
close
relat
human
coronaviru
transmiss
gastroenter
viru
tgev
felin
infecti
periton
viru
fipv
viru
caus
porcin
epidem
diarrhea
enter
diseas
character
acut
wateri
diarrhea
dehydr
clinic
patholog
symptom
pedv
infect
similar
transmiss
gastroenter
make
difficult
differenti
two
although
pedv
becom
enzoot
sever
countri
season
outbreak
result
death
neonat
piglet
well
weight
loss
fatten
pig
continu
caus
seriou
econom
loss
swine
industri
prophylact
vaccin
capabl
prevent
initi
stage
viral
infect
usual
induc
neutral
antibodi
viral
pathogen
due
econom
import
pedv
celladapt
strain
viru
develop
live
attenu
vaccin
vaccin
candid
focus
equival
coe
domain
locat
spike
protein
report
contain
neutral
epitop
pedv
hemagglutin
ha
specif
form
agglutin
involv
red
blood
cell
sever
virus
capabl
induc
hemagglutin
interact
viral
surfac
protein
cellular
receptor
found
surfac
erythrocyt
properti
wide
use
quantit
analysi
sever
virus
includ
orthomyxovirus
paramyxovirus
encephalomyocard
viru
virus
belong
famili
coronavirida
also
report
possess
ha
activ
includ
human
coronaviru
hcov
bovin
coronaviru
bcov
hemagglutin
encephalomyel
viru
hev
tgev
murin
hepat
viru
mhv
avian
infecti
bronchiti
viru
ibv
coronavirus
ha
activ
attribut
presenc
addit
surfac
glycoprotein
hemagglutininesteras
glycoprotein
carri
function
site
hemagglutin
acetylesteras
activ
protein
coronavirus
structur
function
relationship
hemagglutinin
protein
influenza
c
viru
may
deriv
recombin
mrna
influenza
c
viru
genom
rna
ancestr
coronaviru
other
like
ibv
tgev
bcov
spike
protein
observ
possess
sialicacidbind
activ
case
ibv
report
ha
activ
induc
trypsin
neuraminidas
treatment
present
studi
investig
ha
activ
pedv
two
celladapt
strain
pedv
subject
ha
test
erythrocyt
variou
origin
follow
report
describ
prerequisit
condit
induc
ha
activ
pedv
african
green
monkey
kidney
cell
vero
american
type
cultur
collect
atcc
prepar
minimum
essenti
medium
mem
gibco
contain
fetal
bovin
serum
fb
gibco
u
penicillin
lg
streptomycin
lg
ampotericin
b
per
millilit
media
celladapt
strain
korean
pedv
isol
provid
korea
nation
veterinari
quarantin
research
servic
korea
propag
use
vero
cell
follow
method
describ
hofmann
wyler
modif
briefli
vero
cell
inocul
stock
viru
multipl
infect
cultur
serumfre
mem
co
h
viru
harvest
collect
supernat
clarifi
centrifug
rpm
min
virus
kept
use
erythrocyt
obtain
rabbit
pig
chicken
mous
dog
briefli
whole
blood
collect
steril
anticoagul
tube
contain
k
edta
vacutain
bd
bioscienc
immedi
wash
three
time
mm
phosphatebuff
salin
pb
ph
erythrocyt
place
alsev
solut
vv
suspens
kept
maximum
week
ha
test
perform
use
vshape
microtit
plate
spl
labwar
cultur
serumfre
mem
serial
dilut
twofold
pb
contain
wv
bovin
serum
albumin
bsa
fraction
v
merck
sampl
distribut
well
pb
contain
bsa
use
neg
control
erythrocyt
reconstitut
vv
suspens
pb
contain
bsa
aliquot
suspens
ad
well
final
concentr
vv
contain
dilut
viru
mixtur
incub
either
observ
erythrocyt
neg
control
sediment
bottom
well
ha
titer
report
reciproc
valu
maximum
dilut
caus
complet
agglutin
preliminari
find
show
none
erythrocyt
agglutin
presenc
pedv
data
shown
mention
previous
strain
ibv
show
ha
activ
treatment
viru
trypsin
therefor
ha
test
repeat
use
trypsintr
pedv
prior
ha
test
treat
lgml
trypsin
sigma
min
afterward
trypsin
inactiv
lgml
aprotinin
sigma
ha
test
use
erythrocyt
differ
speci
repeat
describ
trypsin
treatment
induc
appreci
ha
activ
erythrocyt
pig
chicken
mous
dog
howev
strain
exhibit
ha
activ
rabbit
erythrocyt
treat
lgml
trypsin
clearli
defin
higher
concentr
fig
base
find
subsequ
ha
test
conduct
rabbit
erythrocyt
viru
pretreat
lgml
trypsin
correl
ha
activ
infecti
titer
pedv
also
investig
vero
cell
grown
confluenc
tc
flask
spl
labwar
inocul
ha
unit
cultur
serumfre
mem
co
sampl
cultur
supernat
taken
h
postinocul
hpi
titrat
focu
format
assay
describ
previous
time
sampl
treat
lgml
trypsin
subject
ha
test
figur
show
compar
level
ha
unitsfocusform
unit
within
period
titer
cultur
supernat
increas
ffu
per
ml
hpi
ffu
per
ml
hpi
similarli
ha
titer
measur
ha
unit
hpi
ha
unit
hpi
posit
correl
ha
titer
infecti
titer
ffa
howev
ratio
ha
unitffu
consist
among
sampl
test
fig
trypsin
treatment
pedv
induc
ha
activ
rabbit
erythrocyt
treat
variou
concentr
trypsin
min
prior
ha
test
spent
cultur
media
noninfect
vero
cell
use
mock
viru
suggest
ha
titer
pedv
precis
translat
infecti
unit
nonetheless
measur
ha
titer
may
suffici
monitor
rate
viru
growth
base
full
genom
sequenc
pedv
strain
genbank
access
viru
lack
protein
respons
ha
activ
coronavirus
like
mhvdvim
hucov
brcv
therefor
primari
assumpt
ha
activ
pedv
attribut
protein
investig
ha
activ
pedv
protein
subject
viru
rabbit
erythrocyt
neuraminidas
treatment
base
sever
report
focus
ha
activ
spike
protein
ibv
tgev
schultz
et
al
report
ha
activ
ibv
tgev
induc
treat
virion
neuraminidas
enzym
remov
alpha
nacetylneuramin
acid
viru
surfac
schwegmann
et
al
show
neuraminidas
treatment
bovin
erythrocyt
less
uml
complet
abolish
agglutin
tgev
indic
larg
amount
sialic
acid
surfac
erythrocyt
necessari
hemagglutin
viru
briefli
prepar
cultur
vero
cell
without
supplement
trypsin
follow
method
describ
earlier
supernat
harvest
h
clarifi
centrifug
viru
suspens
separ
two
group
one
group
treat
lgml
trypsin
describ
earlier
group
treat
muml
neuraminidas
clostridium
perfringen
sigmaaldrich
min
shake
purifi
ultracentrifug
purifi
viru
dilut
origin
volum
use
pb
subject
ha
test
rabbit
erythrocyt
also
treat
uml
neuraminidas
enzym
min
wash
three
time
pb
use
separ
ha
test
two
strain
pedv
similar
effect
trypsin
ha
activ
induc
neuraminidas
treatment
tabl
newli
prepar
cultur
show
ha
titer
ha
unit
trypsin
treatment
ha
unit
respect
neuraminidas
treatment
discrep
ha
titer
obtain
recent
viru
prepar
compar
previou
prepar
may
caus
variat
effici
viru
replic
nontrypsin
condit
nonetheless
result
ha
titer
suffici
particular
studi
differ
ha
activ
trypsintr
neuraminidasetr
viru
attribut
two
factor
effici
viru
recoveri
purif
neuraminidas
treatment
inher
differ
mechan
activ
ha
activ
trypsin
neuraminidas
elucid
studi
meanwhil
neuraminidas
treatment
rabbit
erythrocyt
abolish
ha
activ
pedv
tabl
neuraminidaseinduc
ha
activ
pedv
observ
rabbit
erythrocyt
similar
treatment
establish
erythrocyt
speci
base
find
pedv
possess
ha
activ
even
though
lack
surfac
protein
confer
ha
activ
coronavirus
ha
fig
comparison
ha
titer
infecti
titer
ffa
cultur
supernat
sampl
pedvinfect
vero
cell
variou
time
subject
ha
test
focu
format
assay
infecti
titer
describ
log
ffu
per
ml
ha
titer
describ
ha
unit
activ
pedv
elicit
trypsin
neuraminidas
treatment
suggest
proteolyt
process
remov
nacetylneuramin
acid
viru
surfac
like
spike
protein
respons
attribut
target
erythrocyt
pedv
rabbit
origin
differ
tgev
bovin
origin
ha
activ
share
common
trait
neither
viru
requir
larg
number
surfacebound
sialic
acid
residu
target
erythrocyt
hemagglutin
reaction
ha
use
diagnost
serolog
properti
share
mani
differ
virus
howev
condit
govern
ha
properti
hemagglutinin
differ
depend
viru
previou
studi
report
coronaviru
agglutin
varieti
erythrocyt
special
condit
larg
variat
exist
among
member
famili
coronavirida
abil
agglutin
erythrocyt
hev
readili
agglutin
chicken
erythrocyt
room
temperatur
form
rel
perman
bond
erythrocyt
case
mhv
sever
strain
contain
glycoprotein
mhvdvim
strain
shown
caus
hemagglutin
ha
activ
ibv
first
reveal
trypsin
phospholipas
c
neuraminidas
treatment
noda
et
al
report
tgev
grown
primari
swine
kidney
cell
cultur
agglutin
erythrocyt
chicken
guinea
pig
cattl
erythrocyt
mous
goos
also
found
ha
reaction
effect
inhibit
specif
antiserum
describ
ha
activ
two
differ
strain
pedv
erythrocyt
differ
origin
strain
abl
agglutin
rabbit
erythrocyt
type
erythrocyt
addit
ha
activ
induc
treatment
either
trypsin
neuraminidas
similar
tgev
ibv
basi
result
conclud
ha
activ
pedv
depend
remov
neuramin
acid
virion
surfac
either
trypsin
neuraminidas
treatment
abil
pedv
agglutin
rabbit
erythrocyt
chicken
pig
erythrocyt
use
diagnost
tool
differenti
ped
tge
infect
particularli
use
pedv
tgev
infect
exhibit
similar
clinic
manifest
differenti
method
rtpcr
elisa
commerci
test
kit
rather
expens
studi
need
understand
mechan
pedv
ha
activ
nonetheless
find
provid
primari
insight
develop
new
diagnost
method
pedv
detect
